| Absorption | Bioavailability is 100% (intravenous). |
| Volume of distribution |
|
| Protein binding | 54% |
| Metabolism | Liver via hydroxylation and aromatization of the 3-methyltetrahydroquinoline ring. Age and gender do not substantially affect the pharmacodynamic or pharmacokinetic profile of argatroban. |
| Route of elimination | Argatroban is excreted primarily in the feces (65%), presumably through biliary secretion; 22% is eliminated via urine. |
| Half life | 39 and 51 minutes |
| Clearance |
|
| Toxicity | Excessive bleeding |
| Affected organisms |
|
Argatroban
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment